Glipizide Cas 29094-61-9 China supplier

Glipizide is a second-generation sulfonylurea oral hypoglycemic drug. It mainly promotes the secretion of insulin by pancreatic beta cells, especially the secretion of glucose-stimulated insulin beta cells; it also enhances the effect of insulin, thereby effectively reducing blood sugar concentration and glycosylated hemoglobin; and it can improve hyperlipidemia and reduce triglycerides. and cholesterol levels, increasing the ratio of high-density lipoprotein cholesterol to total cholesterol; it can also inhibit platelet aggregation and promote fibrinolysis, so it may have a certain preventive and therapeutic effect on vascular lesions.